1. Academic Validation
  2. ZDHHC2 promoted antimycobacterial responses by selective autophagic degradation of B-RAF and C-RAF in macrophages

ZDHHC2 promoted antimycobacterial responses by selective autophagic degradation of B-RAF and C-RAF in macrophages

  • Sci Adv. 2025 Jan 24;11(4):eadq7706. doi: 10.1126/sciadv.adq7706.
Junli Sheng 1 2 Xiaolong You 1 2 Dingnai Nie 1 2 Yuling Fu 1 2 Qiao Ling 1 2 Xiaodan Yang 1 2 Yitian Chen 1 2 Li Ma 1 3 4 Shengfeng Hu 1 2
Affiliations

Affiliations

  • 1 Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • 2 Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, The Second Affiliated Hospital, The State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou 510515, China.
  • 3 Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Southern Medical University, Guangzhou, China.
  • 4 Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Guangzhou, China.
Abstract

S-Palmitoylation is a reversible post-translational modification involving saturated fatty acid palmitate-to-cysteine linkage in the protein, which guides many aspects of macrophage physiology in health and disease. However, the precise role and underlying mechanisms of palmitoylation in Mycobacterium tuberculosis Infection of macrophages remain elusive. Here, we found that M. tuberculosis Infection induced the expression of zinc-finger DHHC domain-type palmitoyl-transferases (ZDHHCs), particularly ZDHHC2, in mouse macrophages. Furthermore, ZDHHC2 deficiency in mouse macrophages impaired the immunity against M. tuberculosis and reduced the production of various proinflammatory cytokines. Mechanistic studies revealed the involvement of ZDHHC2 in mediating the palmitoylation of B-RAF and c-Raf, affecting their autophagic degradation and stabilizing protein levels. The increased abundance of B-RAF and c-Raf subsequently increases the activity of the extracellular signal-regulated kinase (ERK) signaling pathway, affecting the survival of M. tuberculosis within macrophages. These findings suggest that ZDHHC2 is a potential target for treating tuberculosis.

Figures
Products